XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value, by Balance Sheet Grouping
The following tables set forth the Company’s cash and cash equivalents and Corporate Securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or long-term notes receivables and other assets, net as of June 30, 2019 and December 31, 2018 (in thousands):
 
June 30, 2019
 
Adjusted Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value
 
Cash and Cash Equivalents
 
Long-Term Notes Receivables and Other Assets, net
Cash
$
3,041

 
$
—

 
$
—

 
$
3,041

 
$
3,041

 
$
—

 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
Money market funds
92

 
—

 
—

 
92

 
92

 
—

 
 
 
 
 
 
 
 
 
 
 
 
Total
$
3,133

 
$
—

 
$
—

 
$
3,133

 
$
3,133

 
$
—

 
December 31, 2018
 
Adjusted Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value
 
Cash and Cash Equivalents
 
Long-Term Notes Receivables and Other Assets, net
Cash
$
6,681

 
$
—

 
$
—

 
$
6,681

 
$
6,681

 
$
—

 
 
 
 
 
 
 
 
 
 
 
 
Level 1:
 
 
 
 
 
 
 
 
 
 
 
Money market funds
6,092

 
—

 
—

 
6,092

 
6,092

 
—

Corporate securities
3,485

 
—

 
(304
)
 
3,181

 
—

 
3,181

Subtotal
9,577

 
—

 
(304
)
 
9,273

 
6,092

 
3,181

 
 
 
 
 
 
 
 
 
 
 
 
Total
$
16,258

 
$
—

 
$
(304
)
 
$
15,954

 
$
12,773

 
$
3,181

Schedule of Long-term Debt Instruments
Components of long-term debt including the associated interest rates and related fair values are as follows (in thousands, except interest rates):
 
 
June 30, 2019
 
December 31, 2018
 
Stated Interest Rate
Issuance
 
Face Value
 
Estimated Fair Value
 
Face Value
 
Estimated Fair Value
 
2020 Notes
 
$
454,299

 
$
431,675

 
$
679,299

 
$
643,568

 
8.750
%
2022 Private Placement Notes
 
270,000

 
258,876

 
270,000

 
257,073

 
8.875
%
2022 Notes
 
900,000

 
862,920

 
900,000

 
855,000

 
7.875
%
2023 Notes
 
400,000

 
326,320

 
400,000

 
326,000

 
7.625
%
2024 Notes
 
225,000

 
215,033

 
—

 
—

 
8.500
%
Term Loan
 
803,925

 
805,950

 
807,975

 
807,975

 
N/A
Total
 
$
3,053,224

 
$
2,900,774

 
$
3,057,274

 
$
2,889,616

 
 
Schedule of Derivative Liabilities at Fair Value
The following table summarizes the fair value and the notional amount of the Company’s outstanding derivative instrument as of June 30, 2019 and December 31, 2018 (in thousands):
 
June 30, 2019
 
December 31, 2018
Consumer Financing Program Contractual Obligations:
 
 
 
Fair value
$
136,254

 
$
117,620

Notional amount
465,864

 
368,708

 
 
 
 
Classified on the condensed consolidated unaudited balance sheets as:
 
 
 
Accrued expenses and other current liabilities
70,468

 
67,710

Other long-term obligations
65,786

 
49,910

Total Consumer Financing Program Contractual Obligation
$
136,254

 
$
117,620

Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation
The following table summarizes the change in the fair value of the Level 3 outstanding derivative liability instrument for the six months ended June 30, 2019 and the twelve months ended December 31, 2018 (in thousands):
 
Six months ended June 30, 2019
 
Twelve months ended December 31, 2018
Balance, beginning of period
$
117,620

 
$
46,496

Additions
47,115

 
93,095

Settlements
(29,908
)
 
(34,587
)
Losses included in earnings
1,427

 
12,616

Balance, end of period
$
136,254

 
$
117,620